Visual Outcomes and Contrast Sensitivity in Patients Implanted With Tecnis Eyhance Intraocular Lens

October 10, 2021 updated by: Andrea Janekova, Faculty Hospital Kralovske Vinohrady

Comparison of Visual Outcomes and Contrast Sensitivity in Patients Implanted With Tecnis Eyhance IOL (Intraocular) and Tecnis Monofocal IOL

To compare visual outcomes for various distances, reading speed, contrast sensitivity, glare occurence, defocus curve and subjective satisfaction in patients implanted with the extended depth of focus lens (Tecnis Eyhance) in one eye and monocal aspheric lens (Tecnis ZCB00) in second eye. Patients undergo visit in 3,6 and 12 months after the surgery.

Study Overview

Detailed Description

The goal of refractive cataract surgery is to remove the opacity, or cataract and to produce the desired refractive outcome. In most cases, the desired outcome is an emmetropic eye, or an eye that sees 20/20 Snellen for distance vision post-surgery with the implant of a monofocal IOL. This, however, does not offer much in the way of intermediate and near vision. The increased desire for simultaneous distance, intermediate and near vision has increased the popularity of multifocal IOLs (MIOLs). However MIOLs provide visual acuity for all distances, they has occurence of optical phenomena such as glare and halo and lower contrast sensitivity. Extended depth of focus (EDOF) lens should provide distance vision as good as monofocal lens and intermediate vision better than monofocal but without any optical phenomenon or decreased contrast sensitivity.

This study is conducted from 11/2019 to 08/2021 in the Ophthalmology department of Faculty Hospital Kralovske Vinohrady in Prague. The research protocol was explained to all participants and informed consent was signed before enrolling patient to the study. The study was approved by the Ethics Committee of Faculty Hospital Kralovske Vinohrady and will enrolled up to 25 patients with presence of cataract in both eyes.

Bilateral clear corneal phacoemulsification and IOL implantation is performed by one surgeon using the same technique in both eyes. The surgical process involved topical anesthesia, superior 3-step clear corneal incision (2,2mm), 5,0mm curvilinear capsulorhexis, phacoemulsification, bilateral irrigation- aspiration and IOL implantation. One eye is implanted with EDOF IOL second eye with monofocal IOL. Type of IOL is chosen randomly and double masked.

Patients are scheduled for visit at 3,6 and 12 months after the surgery.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Czech Republic
      • Prague, Czech Republic, Czechia, 11000
        • Faculty Hospital Královské Vinohrady

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • presence of cataract in both eyes
  • no other ocular pathology affecting visual acuity
  • bilateral phacoemulsification cataract surgery was arranged for both eyes
  • corneal astigmatism up to 0,75 cylinder (measured by IOL Master biometry)
  • dioptric power of both selective lens within 1,5 D range in one patient
  • selecting IOL power between 18 D and 27 D power range

Exclusion Criteria:

  • complicated cataract
  • corneal opacities or irregularities
  • amblyopia
  • anisometropia
  • coexisting ocular pathologies
  • glaucoma
  • history of ocular surgery
  • refusal or unable to maintain follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Extended depth of focus intraocular lens
Eyes of patients implanted with extended depth of focus lens Tecnis Eyhance
Cataract surgery and implantation with extended depth of focus intraocular lens
Active Comparator: Monofocal intraocular lens
Eyes of patients implanted with monofocal lens Tecnis ZCB00
Cataract surgery and implantation with monofocal intraocular lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of visual acuity between eyes implanted with EDOF IOL and eyes implanted with monofocal IOL
Time Frame: 12 months
  • uncorrected distance visual acuity (UDVA)
  • corrected distance visual acuity (CDVA)
  • uncorrected near visual acuity (UNVA)
  • distance corrected near visual acuity (DCNVA)
  • corrected near visual acuity (CNVA)
  • uncorrected intermediate visual acuity (UIVA)
  • distance corrected intermediate visual acuity (DCIVA)
12 months
Comparison of reading speed between eyes implanted with EDOF IOL and eyes implanted with monofocal IOL
Time Frame: 12 months
Monocular reading speed (Salzburg reading desk for 66cm and 80cm)
12 months
Difference in contrast sensitivity between eyes with EDOF IOL and monofocal IOL
Time Frame: 12 months
Contrast sensitivity - CSV (contrast sensitivity vision) 1000 device- monocularly, mesopic, without glare Contrast sensitivity measurement on Glaretester- monocularly- with and without glare
12 months
Comparison of defocus curve between eyes implanted with EDOF IOL and eyes implanted with monofocal IOL
Time Frame: 6 months
A defocus curve that measures visual acuity should be obtained by using the best corrected distance refraction and then defocusing the image in 0.5 increments from +1.5 to -2.5 diopter with spherical plus and spherical minus trial lenses (i.e.,+1.5 D, +1.0 D, +0.5 D, 0.00 D, -0.5 D, -1.00 D, . . . ,-2.50 D) with visual acuity recorded at each change in correction.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionaire
Time Frame: 6 months

Questionaire based on Catquest-9SF (9-item short-form) questionaire with special questions of feeling difference in vision in each eye for various distances Contains questions for activities for various distances with scale of difficulty of doing activity without glasses from 1-4 (1= Yes, very great difficulty, 4= No, no difficulty and Cannot decide answer).

Contains more 3 questions for feeling difference in visual acuity between eyes.

6 months
Change in intermediate visual acuity in eyes implanted with EDOF IOL
Time Frame: 3 and 12 months
  • uncorrected intermediate visual acuity (UIVA) - photopic condition
  • distance corrected intermediate visual acuity (DCIVA)- photopic condition
3 and 12 months
Change in reading speed in eyes implanted with EDOF IOL
Time Frame: 3 and 12 months
Salzburg reading desk for 66cm and 80cm
3 and 12 months
Change in contrast sensitivity in eyes implanted with EDOF IOL
Time Frame: 3 and 12 months
Contrast sensitivity - CSV (contrast sensitivity vision) 1000 device- mesopic, without glare Contrast sensitivity measurement on Glaretester - with and without glare
3 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Janekova, MD, Faculty Hospital Královské Vinohrady

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2019

Primary Completion (Actual)

August 24, 2021

Study Completion (Actual)

August 24, 2021

Study Registration Dates

First Submitted

March 9, 2021

First Submitted That Met QC Criteria

March 14, 2021

First Posted (Actual)

March 16, 2021

Study Record Updates

Last Update Posted (Actual)

October 12, 2021

Last Update Submitted That Met QC Criteria

October 10, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TEY-VAO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraocular Lens

Clinical Trials on TECNIS Eyhance intraocular lens

Subscribe